A Phase One-B (1B) Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions
- Sponsors Genentech
- 20 Feb 2018 Planned End Date changed from 1 Oct 2020 to 1 Dec 2020.
- 20 Feb 2018 Planned primary completion date changed from 1 Oct 2019 to 1 Dec 2019.
- 20 Feb 2018 Status changed from not yet recruiting to recruiting.